Methodological Insights for Randomized Clinical Trials of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a genetically heterogeneous group of photoreceptor degenerations for which no treatments exist. In this issue of JAMA Ophthalmology, Birch and colleagues1 report on the repurposing of oral valproic acid as a potential treatment for autosomal dominant RP. The authors…